171 related articles for article (PubMed ID: 10617139)
1. Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.
McLoughlin DJ; Strange PG
J Neurochem; 2000 Jan; 74(1):347-57. PubMed ID: 10617139
[TBL] [Abstract][Full Text] [Related]
2. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
Jerning E; Rosqvist S; Mohell N
J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
4. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.
Thomas DR; Faruq SA; Balcarek JM; Brown AM
J Recept Signal Transduct Res; 1995; 15(1-4):199-211. PubMed ID: 8903941
[TBL] [Abstract][Full Text] [Related]
6. Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding.
Dupuis DS; Palmier C; Colpaert FC; Pauwels PJ
J Neurochem; 1998 Mar; 70(3):1258-68. PubMed ID: 9489749
[TBL] [Abstract][Full Text] [Related]
7. Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):551-61. PubMed ID: 9402034
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
9. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Millan MJ
Neuropharmacology; 1997; 36(4-5):451-9. PubMed ID: 9225269
[TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Newman-Tancredi A; Gavaudan S; Conte C; Chaput C; Touzard M; Verrièle L; Audinot V; Millan MJ
Eur J Pharmacol; 1998 Aug; 355(2-3):245-56. PubMed ID: 9760039
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors.
Pauwels PJ; Dupuis DS; Perez M; Halazy S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):404-10. PubMed ID: 9826061
[TBL] [Abstract][Full Text] [Related]
12. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic studies of 5-HT1A-receptor-stimulated [35S]GTPgammaS-binding responses in the human and monkey brain.
Dupuis DS; Pauwels PJ; Radu D; Hall H
Eur J Neurosci; 1999 May; 11(5):1809-17. PubMed ID: 10215933
[TBL] [Abstract][Full Text] [Related]
14. Native rat hippocampal 5-HT1A receptors show constitutive activity.
Martel JC; Ormière AM; Leduc N; Assié MB; Cussac D; Newman-Tancredi A
Mol Pharmacol; 2007 Mar; 71(3):638-43. PubMed ID: 17167032
[TBL] [Abstract][Full Text] [Related]
15. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
Newman-Tancredi A; Cussac D; Marini L; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635.
Newman-Tancredi A; Conte C; Chaput C; Spedding M; Millan MJ
Br J Pharmacol; 1997 Mar; 120(5):737-9. PubMed ID: 9138675
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Mol Pharmacol; 2004 Dec; 66(6):1573-9. PubMed ID: 15340043
[TBL] [Abstract][Full Text] [Related]
18. Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity.
Happe HK; Bylund DB; Murrin LC
Eur J Pharmacol; 2001 Jun; 422(1-3):1-13. PubMed ID: 11430907
[TBL] [Abstract][Full Text] [Related]
19. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
20. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
